Purpose: Early identification of patients at risk of developing colorectal liver metastases can help personalizing treatment and improve oncological outcome. The aim of this study was to investigate in patients with colorectal cancer (CRC) whether a machine learning-based radiomics model can predict the occurrence of metachronous metastases. Methods: In this multicentre study, the primary staging portal venous phase CT of 91 CRC patients were retrospectively analysed. Two groups were assessed: patients without liver metastases at primary staging, or during follow-up of ≥ 24 months (n = 67) and patients without liver metastases at primary staging but developed metachronous liver metastases < 24 months after primary staging (n = 24). After...
BackgroundThe liver is the most common site of distant metastasis in rectal cancer, and liver metast...
Featured Application Based on results defined in this study, new investigations might propose morpho...
Colorectal cancer (CRC) is the third most common malignancy worldwide, with approximately 50% of pat...
Purpose: Early identification of patients at risk of developing colorectal liver metastases can help...
Colorectal cancer (CRC) has the second-highest tumor incidence and is a leading cause of death by ca...
Purpose: We aimed to assess the efficacy of radiomic features extracted by computed tomography (CT) ...
Medical imaging gives valuable information for diagnosis and treatment planning of cancer patients. ...
Background Patients with colorectal liver metastases (CRLM) who undergo thermal ablation are at risk...
The aim of this study was to develop and validate a new non-invasive artificial intelligence (AI) mo...
Background and Purpose: Prognostic assessment of local therapies for colorectal liver metastases (CL...
Purpose Predicting early local tumor progression after thermal ablation treatment for colorectal liv...
Liver metastases (mts) from colorectal cancer (CRC) can have different responses to chemotherapy in ...
Histopathological growth patterns (HGPs) are independent prognosticators for colorectal liver metast...
To assess Radiomics and Machine Learning Analysis in Liver Colon and Rectal Cancer Metastases (CRLM)...
BackgroundThe liver is the most common site of distant metastasis in rectal cancer, and liver metast...
BackgroundThe liver is the most common site of distant metastasis in rectal cancer, and liver metast...
Featured Application Based on results defined in this study, new investigations might propose morpho...
Colorectal cancer (CRC) is the third most common malignancy worldwide, with approximately 50% of pat...
Purpose: Early identification of patients at risk of developing colorectal liver metastases can help...
Colorectal cancer (CRC) has the second-highest tumor incidence and is a leading cause of death by ca...
Purpose: We aimed to assess the efficacy of radiomic features extracted by computed tomography (CT) ...
Medical imaging gives valuable information for diagnosis and treatment planning of cancer patients. ...
Background Patients with colorectal liver metastases (CRLM) who undergo thermal ablation are at risk...
The aim of this study was to develop and validate a new non-invasive artificial intelligence (AI) mo...
Background and Purpose: Prognostic assessment of local therapies for colorectal liver metastases (CL...
Purpose Predicting early local tumor progression after thermal ablation treatment for colorectal liv...
Liver metastases (mts) from colorectal cancer (CRC) can have different responses to chemotherapy in ...
Histopathological growth patterns (HGPs) are independent prognosticators for colorectal liver metast...
To assess Radiomics and Machine Learning Analysis in Liver Colon and Rectal Cancer Metastases (CRLM)...
BackgroundThe liver is the most common site of distant metastasis in rectal cancer, and liver metast...
BackgroundThe liver is the most common site of distant metastasis in rectal cancer, and liver metast...
Featured Application Based on results defined in this study, new investigations might propose morpho...
Colorectal cancer (CRC) is the third most common malignancy worldwide, with approximately 50% of pat...